Company Filing History:
19 out of 185 
18 out of 223 
14 out of 5,307 
Years Active: 2002-2025
Title: Innovations and Contributions of Jan Steyaert
Introduction
Jan Steyaert, based in Beersel, Belgium, is an accomplished inventor with a remarkable portfolio consisting of 20 patents. His work primarily focuses on structural biology and G-protein-coupled receptors (GPCRs), which are pivotal in the field of drug discovery and therapeutic development.
Latest Patents
Steyaert's latest innovations include:
1. **Protein Binding Domains Stabilizing Functional Conformational States of GPCRs and Uses Thereof** - This invention pertains to GPCR structural biology and signaling. It offers protein binding domains that enhance the stability of GPCRs in their active conformational states, aiding in the functional characterization of these receptors. The utility of this discovery extends to drug discovery and therapeutic applications for GPCR-related diseases.
2. **Antigen-Binding Chimeric Proteins and Methods and Uses Thereof** - This patent introduces novel antigen-binding chimeric proteins that facilitate three-dimensional structural analysis of macromolecules. These proteins can be instrumental in various applications, including therapeutic and diagnostic tools, leveraging techniques like X-ray crystallography and high-resolution Cryo-Electron Microscopy.
Career Highlights
Throughout his career, Jan Steyaert has made significant strides in his field while working with reputable organizations. He has been associated with Vib Vzw and the Vrije Universiteit Brussel, where he has contributed to numerous research initiatives and innovative projects that have propelled advancements in structural biology.
Collaborations
Steyaert has collaborated with esteemed colleagues, including Els Pardon and Toon Laeremans. These collaborative efforts have resulted in impactful research findings and have enhanced the understanding of protein interactions and functions.
Conclusion
Jan Steyaert's contributions to the field of structural biology and his innovative inventions have been instrumental in advancing the understanding of GPCRs. His patented technologies hold promise for significant applications in drug discovery and therapeutic interventions, marking him as a noteworthy inventor in his domain.